Conference Presentations

PLENARY SESSIONS

ISSUE PANEL PRESENTATIONS

  • IP10 : ESQUEMAS DE PRECIO BASADOS EN EL VALOR... ¿SEGURO QUE NO ES SUEÑO?

    Presentation

    Diego Lencina
    BS, Director, Azistia, Buenos Aires, Argentina
  • IP10 : ESQUEMAS DE PRECIO BASADOS EN EL VALOR... ¿SEGURO QUE NO ES SUEÑO?

    Presentation

    German De La llave
    MD, Medical Head, ASE MEDIFE, Buenos Aires, Argentina
  • IP10 : ESQUEMAS DE PRECIO BASADOS EN EL VALOR... ¿SEGURO QUE NO ES SUEÑO?

    Presentation

    Lucas Najun Dubos
    MD, MHE, Access Planning & HEOR Manager, Roche Argentina, Buenos Aires, Argentina
  • IP10 : ESQUEMAS DE PRECIO BASADOS EN EL VALOR... ¿SEGURO QUE NO ES SUEÑO?
  • IP11 : LIMIAR DE DISPOSIÇÃO A PAGAR NO BRASIL: POSSÍVEIS CAMINHOS

    Presentation

    Rodrigo Antonini Ribeiro
    MD, MSc, PhD, Managing Partner and Researcher, HTAnalyze and IATS, Porto Alegre, Brazil
  • IP11 : LIMIAR DE DISPOSIÇÃO A PAGAR NO BRASIL: POSSÍVEIS CAMINHOS

    Presentation

    Everton Nunes Silva
    PhD, Professor, University of Brasilia, Public Health, Brasília, Brazil
  • IP11 : LIMIAR DE DISPOSIÇÃO A PAGAR NO BRASIL: POSSÍVEIS CAMINHOS

    Presentation

    Alexander Itria
    researcher, HEAD, GOIAS UNIVERSITY, HEALTH ECONOMY, goiânia, Brazil
  • IP3 : LOS DESAFIOS DE LAS ENFERMEDADES RARAS EN LA REGIÓN: EQUILIBRIO ENTRE EL ACCESO Y ACCESIBILIDAD (Invited Issue Panel)

    Presentation

    Angela Chaves
    DO, Presidente, Federación Colombiana de Enfermedades Raras, Bogotá, Colombia
  • IP3 : LOS DESAFIOS DE LAS ENFERMEDADES RARAS EN LA REGIÓN: EQUILIBRIO ENTRE EL ACCESO Y ACCESIBILIDAD (Invited Issue Panel)
  • IP4 : COST-EFFECTIVENESS THRESHOLDS IN LATIN AMERICA: WHAT CAN WE LEARN FROM REGIONAL AND INTERNATIONAL EXPERIENCES? (Invited Issue Panel)

    Presentation

    Hector Castro
    MD, MS, PhD, Chief Executive Officer, Health Technology Assessment Institute of Colombia (IETS), Bogota, Colombia
  • IP5 : DESAFIOS NOS SISTEMAS DE SAÚDE DA AMÉRICA LATINA: QUAIS EVIDÊNCIAS DE MUNDO REAL SÃO NECESSÁRIAS PARA ESTIMAR VALOR DE EQUIPAMENTOS MÉDICO-ASSISTENCIAIS E TESTES DIAGNÓSTICOS EM UM PROCESSO DE AVALIAÇÃO DE TECNOLOGIAS EM SAÚDE?

    Presentation

    Cristina Nunes Ferreira
    MSc, MBA, HEOR & Pricing Manager, Pfizer Inc., São Paulo, Brazil
  • IP6 : TECHNOLOGY ENABLED PATIENT ADHERENCE PROGRAMS AS A SOURCE OF REAL-WORLD EVIDENCE: OPPORTUNITIES IN LATIN AMERICA

    Presentation

    Miguel Martin de Bustamante
    BA, Senior Associate, CBPartners, San Francisco, USA
    Diego F Guarin
    MD, MPH, MA, Senior Director, HEOR & HTA Strategy, Merck-Serono, HEOR & HTA, Latin America, Billerica, USA
    Sandeep Duttagupta
    PhD, Principal, CBPartners, New York, USA
  • IP7 : RISK SHARING AGREEMENTS: PERSPECTIVES AND CHALLENGES FOR THEIR IMPLEMENTATION IN LATIN AMERICA: A MULTI-STAKEHOLDERS DEBATE
  • IP7 : RISK SHARING AGREEMENTS: PERSPECTIVES AND CHALLENGES FOR THEIR IMPLEMENTATION IN LATIN AMERICA: A MULTI-STAKEHOLDERS DEBATE

    Presentation

    Daniela Paredes Fernandez
    BSc, RM, MPH, Assistant Professor, Universidad de Chile, Departamento Promoción de la Salud de la Mujer y el Recién Nacido, Santiago, Chile
  • IP7 : RISK SHARING AGREEMENTS: PERSPECTIVES AND CHALLENGES FOR THEIR IMPLEMENTATION IN LATIN AMERICA: A MULTI-STAKEHOLDERS DEBATE

    Presentation

    Rony Lenz Alcayaga
    MSc, Professor, University of Chile, School of Public Health, Santiago, Chile
  • IP7 : RISK SHARING AGREEMENTS: PERSPECTIVES AND CHALLENGES FOR THEIR IMPLEMENTATION IN LATIN AMERICA: A MULTI-STAKEHOLDERS DEBATE
  • IP8 : EL CONCEPTO DE VALOR

    Presentation

    Jaime Calderón
    MD, Director Ejecutivo, Instituto de Evaluación Tecnológica en Salud, Bogotá, Colombia
  • IP8 : EL CONCEPTO DE VALOR

    Presentation

    Angela Chaves
    DO, Presidente, Federación Colombiana de Enfermedades Raras, Bogotá, Colombia
  • IP8 : EL CONCEPTO DE VALOR
  • IP9 : ANÁLISE DE DECISÃO MULTI-CRITÉRIOS (MCDA) NA AMÉRICA LATINA (Invited Issue Panel)

    Presentation

    Laura Murta Amaral
    MSc, Project manager, SENSE Company, RJ, Brazil
    Joice Valentim
    MSc DSc, Latin America HTA & Reimbursement Policy Lead, Roche Pharma, LA, São Paulo, Brazil

WORKSHOP PRESENTATIONS

  • W1 : MÉTODOS EM EVOLUÇÃO PARA A GERAÇÃO DE EVIDÊNCIAS DE MUNDO REAL EM MERCADOS MADUROS E EMERGENTES
  • W10 : HEALTH ECONOMICS AND OUTCOMES RESEARCH NEEDS ASSESSMENT FOR LATIN AMERICA: RELATIONSHIP BETWEEN PERCEIVED AND EXPECTED QUALITY OF KNOWLEDGE IN A SELF-ASSESSMENT SURVEY (Invited Workshop)

    Presentation

    Andre Ferreira Azeredo-da-Silva
    MD, PhD, Internal Medicine Physician, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
  • W10 : HEALTH ECONOMICS AND OUTCOMES RESEARCH NEEDS ASSESSMENT FOR LATIN AMERICA: RELATIONSHIP BETWEEN PERCEIVED AND EXPECTED QUALITY OF KNOWLEDGE IN A SELF-ASSESSMENT SURVEY (Invited Workshop)

    Presentation

    Iris Contreras
    MD, MSc, Investigadora Asociada, Instituto Mexicano del Seguro Social, Hospital General de Zona 1A Venados, Mexico D.F., Mexico
  • W2 : APPROACHES FOR PRIORITY SETTING: IS THERE A BEST WAY?

    Presentation

    Aurelio Mejia
    MSc, Senior Economist, Instituto de Evaluación Tecnológica en Salud, Health Technology Assessment, Bogotá, Colombia
  • W2 : APPROACHES FOR PRIORITY SETTING: IS THERE A BEST WAY?
  • W4 : INCORPORACIÓN DE REPRESENTANTES DE PACIENTES EN PROCESOS DE DECISIÓN DE COBERTURA EN SALUD: AVANCES Y DESAFÍOS PARA LATINOAMÉRICA

    Presentation

    Cecilia Rodriguez
    MPH, Directora, Fundación Me Muevo, Santiago, Chile
  • W4 : INCORPORACIÓN DE REPRESENTANTES DE PACIENTES EN PROCESOS DE DECISIÓN DE COBERTURA EN SALUD: AVANCES Y DESAFÍOS PARA LATINOAMÉRICA
  • W4 : INCORPORACIÓN DE REPRESENTANTES DE PACIENTES EN PROCESOS DE DECISIÓN DE COBERTURA EN SALUD: AVANCES Y DESAFÍOS PARA LATINOAMÉRICA

    Presentation

    Báltica Cabieses
    MSc, PhD, Professor, Universidad del Desarrollo, Facultad de Medicina- Clínica Alemana, Santiago, Chile
  • W5 : AVALIAÇÃO DE VALOR EM MEDICAL DEVICES NA PERSPECTIVA LATINO AMERICANA (Invited Workshop)

    Presentation

    Marcelo Katz
    MD, Senior Researcher, Hospital Israelita Albert Einstein, Value Management Office, Sao Paulo, Brazil
  • W5 : AVALIAÇÃO DE VALOR EM MEDICAL DEVICES NA PERSPECTIVA LATINO AMERICANA (Invited Workshop)

    Presentation

    Lucila Rey-Ares
    MD; MSc, Lead, CEMIC, Health Technology and Audit Committee, Buenos Aires, Argentina
  • W5 : AVALIAÇÃO DE VALOR EM MEDICAL DEVICES NA PERSPECTIVA LATINO AMERICANA (Invited Workshop)

    Presentation

    Ramiro E. Gilardino
    MD, MSc, Director, International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Global Networks Latin America, Lawrenceville, USA
  • W5 : AVALIAÇÃO DE VALOR EM MEDICAL DEVICES NA PERSPECTIVA LATINO AMERICANA (Invited Workshop)

    Presentation

    Silvio Mauro Junqueira Junior
    MD, Health Economics & Market Access Senior Manager, Johnson & Johnson Medical Brazil, Health Economics, São Paulo, Brazil
  • W6 : EXPERIENCIA DE TRABAJO COLABORATIVO ENTRE PAISES DE AMÉRICA LATINA PARA LA TOMA DE DECISIONES INFORMADAS DE MEDICAMENTOS: PROYECTO DIME

    Presentation

    Rosa María Galindo-Suárez
    MHE, Deputy General Director of Prioritization, Ministry of Health, General Health Council, Mexico City, Mexico
    Constanza Vargas
    MSc, HTA Research Coordinator, Pontificia Universidad Catolica de Chile, Centro de Investigacion Clinica UC, Santiago, Chile
    Ana Lucía Muñoz Mejía
    Esp., Especialista Sénior de Protección Social, Banco Interamericano de Desarrollo, Proyecto Regional sobre Priorización y Planes de Beneficios en Salud, Bogotá, Colombia
    Claudia Vaca
    MSc, Directora Tecnica Proyecto DIME/Profesor Asistente, Universidad Nacional de Colombia, Bogota, Colombia
    Hernando Gaitán
    MD, Professor, Universidad Nacional de Colombia, Departamento de Obstetricia y Ginecología, Bogota, Colombia
  • W8 : USO DE LA EVIDENCIA DEL MUNDO REAL (RWE) EN LA TOMA DE DECISIONES EN SALUD: LOS CASOS DE ARGENTINA, CHILE Y COLOMBIA

    Presentation

    Nahila Justo
    MPhil, MSc, MBA, Associate Director, Optum, Stockholm, Sweden
  • W8 : USO DE LA EVIDENCIA DEL MUNDO REAL (RWE) EN LA TOMA DE DECISIONES EN SALUD: LOS CASOS DE ARGENTINA, CHILE Y COLOMBIA
  • W8 : USO DE LA EVIDENCIA DEL MUNDO REAL (RWE) EN LA TOMA DE DECISIONES EN SALUD: LOS CASOS DE ARGENTINA, CHILE Y COLOMBIA

    Presentation

    Manuel A. Espinoza
    MD, MSc, PhD, Professor, Catholic University of Chile, Public Health Department, Santiago, Chile
  • W8 : USO DE LA EVIDENCIA DEL MUNDO REAL (RWE) EN LA TOMA DE DECISIONES EN SALUD: LOS CASOS DE ARGENTINA, CHILE Y COLOMBIA

    Presentation

    Sebastian Garcia
    MD, MSc, Coordinator, IECS, Departamento Evaluación de Tecnologías Sanitarias y Evaluaciones Económicas, Buenos Aires, Argentina
  • W9 : RECENT EXPERIENCES USING THE EUROQOL EQ-5D INSTRUMENT IN LATIN AMERICA: THE 3L&5L; PUBLIC HEALTH AND ECONOMIC EVALUATIONS; NEWER TIME TRADE OFF VARIANTS AND DISCRETE CHOICE EXPERIMENTS
  • W9 : RECENT EXPERIENCES USING THE EUROQOL EQ-5D INSTRUMENT IN LATIN AMERICA: THE 3L&5L; PUBLIC HEALTH AND ECONOMIC EVALUATIONS; NEWER TIME TRADE OFF VARIANTS AND DISCRETE CHOICE EXPERIMENTS

    Presentation

    Victor Zarate
    MD, Investigator, Ministerio de Salud, DIPLAS, Santiago, Chile
  • W9 : RECENT EXPERIENCES USING THE EUROQOL EQ-5D INSTRUMENT IN LATIN AMERICA: THE 3L&5L; PUBLIC HEALTH AND ECONOMIC EVALUATIONS; NEWER TIME TRADE OFF VARIANTS AND DISCRETE CHOICE EXPERIMENTS

    Presentation

    Henry H. Bailey
    PhD, Lecturer, The University of the West Indies, Arthur Lok Jack Graduate School of Business and the Centre for Health Economics, Mt. Hope, Trinidad and Tobago

ISPOR FORUMS

  • F1 : REGULATION IN HEALTH SYSTEMS AND EQUITY: LESSONS LEARNED AND FUTURE PERSPECTIVES FROM AN INEQUITABLE REGION IN THE WORLD

    Presentation

    Edward M.A. Mezones-Holguín
    MD, MSc, Jefe, Escuela de Postgrado, Universidad San Ignacio de Loyola, Lima, Peru
  • F1 : REGULATION IN HEALTH SYSTEMS AND EQUITY: LESSONS LEARNED AND FUTURE PERSPECTIVES FROM AN INEQUITABLE REGION IN THE WORLD

    Presentation

    Baltica Cabieses
    MSc, PhD, Senior Lecturer, Universidad del Desarrollo, Faculty of Medicine- Clinica Alemana, Santiago, Chile
  • F1 : REGULATION IN HEALTH SYSTEMS AND EQUITY: LESSONS LEARNED AND FUTURE PERSPECTIVES FROM AN INEQUITABLE REGION IN THE WORLD

    Presentation

    Raquel Medeiros Lisbôa
    MD, General Manager, Agencia Nacional de Saude Complementar, Healthcare Regulation, Rio de Janeiro, Brazil
  • F1 : REGULATION IN HEALTH SYSTEMS AND EQUITY: LESSONS LEARNED AND FUTURE PERSPECTIVES FROM AN INEQUITABLE REGION IN THE WORLD
  • F2 : DATOS Y EVIDENCIAS DEL MUNDO REAL EN LATINOAMÉRICA: ¿REALIDAD O FICCIÓN?

    Presentation

    Natalia Jorgensen
    MSc, Advisor, Ministry of Health, Buenos Aires, Argentina
  • F2 : DATOS Y EVIDENCIAS DEL MUNDO REAL EN LATINOAMÉRICA: ¿REALIDAD O FICCIÓN?

    Presentation

    Mariana Glancszpigel
    Actuaria, Directora, 3Eff S.A., Buenos Aires, Argentina
  • F2 : DATOS Y EVIDENCIAS DEL MUNDO REAL EN LATINOAMÉRICA: ¿REALIDAD O FICCIÓN?

    Presentation

    Gerardo Machnicki
    MSc, PhD, Director, Janssen, Real World Evidence LATAM, Buenos Aires, Argentina
  • F2 : DATOS Y EVIDENCIAS DEL MUNDO REAL EN LATINOAMÉRICA: ¿REALIDAD O FICCIÓN?
  • F3 : ADAPTIVE PATHWAYS AND PATIENT ACCESS – IS THERE A PLACE FOR NEW PAYMENT MODELS?
  • F3 : ADAPTIVE PATHWAYS AND PATIENT ACCESS – IS THERE A PLACE FOR NEW PAYMENT MODELS?
  • F3 : ADAPTIVE PATHWAYS AND PATIENT ACCESS – IS THERE A PLACE FOR NEW PAYMENT MODELS?

    Presentation

    Rosa Maria Galindo Suarez
    MHA, Deputy General Director of Prioritization, General Health Council, Mexico City, Mexico
  • F3 : ADAPTIVE PATHWAYS AND PATIENT ACCESS – IS THERE A PLACE FOR NEW PAYMENT MODELS?

    Presentation

    Marcelo Fonseca
    MD, MSc, Professor, Federal University of São Paulo, Assistant Physician, São Paulo, Brazil